Literature DB >> 31034892

Increased Aggregation Tendency of Alpha-Synuclein in a Fully Disordered Protein Complex.

David A Merle1, Anja Witternigg1, Carmen Tam-Amersdorfer2, Christoph Hartlmüller3, Emil Spreitzer4, Evelyne Schrank1, Sabine Wagner-Lichtenegger5, Oliver Werzer6, Klaus Zangger1, Andreas J Kungl6, Tobias Madl7, N Helge Meyer8, S Fabio Falsone9.   

Abstract

The recent discovery of biologically active fully disordered, so called random fuzzy protein-protein interactions leads to the question of how the high flexibility of these protein complexes correlates to aggregation and pathologic misfolding. We identify the structural mechanism by which a random fuzzy protein complex composed of the intrinsically disordered proteins alpha-Synuclein and SERF1a is able to potentiate cytotoxic aggregation. A structural model derived from an integrated NMR/SAXS analysis of the reconstituted aSyn:SERF1a complex enabled us to observe the partial deprotection of one precise aSyn amyloid nucleation element in the fully unstructured ensemble. This minimal exposure was sufficient to increase the amyloidogenic tendency of SERF1a-bound aSyn. Our findings provide a structural explanation of the previously observed pro-amyloid activity of SERF1a. They further demonstrate that random fuzziness can trigger a structurally organized disease-associated reaction such as amyloid polymerization.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alpha synuclein; Amyloids; Fuzzy complexes; Intrinsically disordered proteins; MOAG-4/SERF

Mesh:

Substances:

Year:  2019        PMID: 31034892     DOI: 10.1016/j.jmb.2019.04.031

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  3 in total

1.  SERF engages in a fuzzy complex that accelerates primary nucleation of amyloid proteins.

Authors:  Ben A Meinen; Varun V Gadkari; Frederick Stull; Brandon T Ruotolo; James C A Bardwell
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-28       Impact factor: 11.205

2.  A novel knockout mouse for the small EDRK-rich factor 2 (Serf2) showing developmental and other deficits.

Authors:  Karen Cleverley; Weaverly Colleen Lee; Paige Mumford; Toby Collins; Matthew Rickman; Thomas J Cunningham; James Cleak; Joffrey Mianne; Zsombor Szoke-Kovacs; Michelle Stewart; Lydia Teboul; Cheryl Maduro; Sara Wells; Frances K Wiseman; Elizabeth M C Fisher
Journal:  Mamm Genome       Date:  2021-03-13       Impact factor: 2.957

3.  The cellular modifier MOAG-4/SERF drives amyloid formation through charge complementation.

Authors:  Anita Pras; Bert Houben; Francesco A Aprile; Renée Seinstra; Rodrigo Gallardo; Leen Janssen; Wytse Hogewerf; Christian Gallrein; Matthias De Vleeschouwer; Alejandro Mata-Cabana; Mandy Koopman; Esther Stroo; Minke de Vries; Samantha Louise Edwards; Janine Kirstein; Michele Vendruscolo; Salvatore Fabio Falsone; Frederic Rousseau; Joost Schymkowitz; Ellen A A Nollen
Journal:  EMBO J       Date:  2021-10-07       Impact factor: 11.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.